Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a physician-owned contract research organization (CRO) that conducts clinical trials in a broad range of diseases related to wound healing. To promote clinical research in the burgeoning field of wound care, SerenaGroup® established a site management organization (SMO) that assists hospitals and clinics in establishing compliant research programs. In addition, SerenaGroup® provides consulting services for advanced wound and hyperbaric centers across the globe. Dr. Serena completed his residency in Surgery at Penn State and maintains board certification in Surgery. Dr. Serena operates advanced wound care and research centers across the United Sates and globally. He has been the lead or Principal investigator in over 150 clinical trials, including diagnostics, antimicrobial dressings, growth factors, and CAMP therapy. He is one of the world leaders in clinical research, quality improvement, and real-world data collection. He holds numerous patents on wound care devices and dressings. He is recognized internationally as an expert in the field of wound healing: He has more than 350 published papers and has given more than 2500 invited lectures throughout the world. He has been a member of the Board of Directors of the Wound Healing Society He is a Past President of the Association for the Advancement of Wound Care (AAWC) and American Professional Wound Care Association. He is the Vice-President of the International Surgical Wound Complication Advisory Board (ISWCAP). In 2024, he founded the international Post-Acute Wound Society (iPAWS). .